GlassScriptPhysician profile
David C Templeman
NPI 1750387734
$361,481.07
in general payments reported to CMS, 2019-2025
9 companies · $39K in 2025
The $39K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123K · 2020: $52K · 2021: $32K · 2022: $35K · 2023: $42K · 2024: $40K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $60K · Royalty Or License: $43K · Travel and Lodging: $14K · Food and Beverage: $2,091 · Education: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,250.00 |
| Royalty Or License | $43,494.12 |
| Travel and Lodging | $13,659.66 |
| Food and Beverage | $2,090.99 |
| Education | $419.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $142,867.88 | 2019-2025 | |
| Stryker Corporation | $118,097.58 | 2019-2025 | Pro, Asnis, Gamma |
| Orthofix Medical, INC. | $99,924.70 | 2019-2025 | Chimaera Hip Fracture System, Physio-Stim |
| Philips North America LLC | $300.00 | 2020 | |
| US Implant Solutions, LLC | $87.31 | 2024 | |
| Globus Medical, INC. | $84.64 | 2023 | Evo Antegrade |
| Ossdsign USA Incorporated | $84.12 | 2025 | Ossdsign Catalyst |
| Depuy Synthes Sales INC. | $18.47 | 2024 | Na |
| Pacira Pharmaceuticals Incorporated | $16.37 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Templeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.